Meltzer HY - Search Results

1

Serotonin receptors: their key role in drugs to treat schizophrenia.

Meltzer HY, Li Z, Kaneda Y, Ichikawa J. Meltzer HY, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2003 Oct;27(7):1159-72. doi: 10.1016/j.pnpbp.2003.09.010. Prog Neuropsychopharmacol Biol Psychiatry. 2003. PMID: 14642974 Review.

2

RNA editing of the human serotonin 5-HT2C receptor. alterations in suicide and implications for serotonergic pharmacotherapy.

Niswender CM, Herrick-Davis K, Dilley GE, Meltzer HY, Overholser JC, Stockmeier CA, Emeson RB, Sanders-Bush E. Niswender CM, et al. Among authors: meltzer hy. Neuropsychopharmacology. 2001 May;24(5):478-91. doi: 10.1016/S0893-133X(00)00223-2. Neuropsychopharmacology. 2001. PMID: 11282248

3

Atypical, but not typical, antipsychotic drugs increase cortical acetylcholine release without an effect in the nucleus accumbens or striatum.

Ichikawa J, Dai J, O'Laughlin IA, Fowler WL, Meltzer HY. Ichikawa J, et al. Among authors: meltzer hy. Neuropsychopharmacology. 2002 Mar;26(3):325-39. doi: 10.1016/S0893-133X(01)00312-8. Neuropsychopharmacology. 2002. PMID: 11850147

4

5-HT(1A) and 5-HT(2A) receptors minimally contribute to clozapine-induced acetylcholine release in rat medial prefrontal cortex.

Ichikawa J, Dai J, Meltzer HY. Ichikawa J, et al. Among authors: meltzer hy. Brain Res. 2002 Jun 7;939(1-2):34-42. doi: 10.1016/s0006-8993(02)02544-1. Brain Res. 2002. PMID: 12020849

5

Assessing cardiovascular risks versus clinical benefits of atypical antipsychotic drug treatment.

Meltzer HY, Davidson M, Glassman AH, Vieweg WV. Meltzer HY, et al. J Clin Psychiatry. 2002;63 Suppl 9:25-9. J Clin Psychiatry. 2002. PMID: 12088173 Review.

6

Suicidality in schizophrenia: a review of the evidence for risk factors and treatment options.

Meltzer HY. Meltzer HY. Curr Psychiatry Rep. 2002 Aug;4(4):279-83. doi: 10.1007/s11920-996-0047-6. Curr Psychiatry Rep. 2002. PMID: 12126596 Review.

7

5-HT(2A) receptor antagonism potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and inhibits that in the nucleus accumbens in a dose-dependent manner.

Liégeois JF, Ichikawa J, Meltzer HY. Liégeois JF, et al. Among authors: meltzer hy. Brain Res. 2002 Aug 30;947(2):157-65. doi: 10.1016/s0006-8993(02)02620-3. Brain Res. 2002. PMID: 12176156

8

Commentary on "clinical studies on the mechanism of action of clozapine; the dopamine-serotonin hypothesis of schizophrenia." Psychopharmacology (1989) 99:S18-S27.

Meltzer HY. Meltzer HY. Psychopharmacology (Berl). 2002 Aug;163(1):1-3. doi: 10.1007/s00213-002-1088-0. Epub 2002 Jul 5. Psychopharmacology (Berl). 2002. PMID: 12185394 No abstract available.

9

SR46349-B, a 5-HT(2A/2C) receptor antagonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.

Bonaccorso S, Meltzer HY, Li Z, Dai J, Alboszta AR, Ichikawa J. Bonaccorso S, et al. Among authors: meltzer hy. Neuropsychopharmacology. 2002 Sep;27(3):430-41. doi: 10.1016/S0893-133X(02)00311-1. Neuropsychopharmacology. 2002. PMID: 12225700

10

The effect of melperone, an atypical antipsychotic drug, on cognitive function in schizophrenia.

Sumiyoshi T, Jayathilake K, Meltzer HY. Sumiyoshi T, et al. Among authors: meltzer hy. Schizophr Res. 2003 Jan 1;59(1):7-16. doi: 10.1016/s0920-9964(01)00329-2. Schizophr Res. 2003. PMID: 12413636 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results